Cargando…
LRRC superfamily expression in stromal cells predicts the clinical prognosis and platinum resistance of ovarian cancer
BACKGROUND: Leucine-rich repeat sequence domains are known to mediate protein‒protein interactions. Recently, some studies showed that members of the leucine rich repeat containing (LRRC) protein superfamily may become new targets for the diagnosis and treatment of tumours. However, it is not known...
Autores principales: | Zhu, Xiaoying, You, Shijing, Du, Xiuzhen, Song, Kejuan, Lv, Teng, Zhao, Han, Yao, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850808/ https://www.ncbi.nlm.nih.gov/pubmed/36653841 http://dx.doi.org/10.1186/s12920-023-01435-9 |
Ejemplares similares
-
SLC7A1 Overexpression Is Involved in Energy Metabolism Reprogramming to Induce Tumor Progression in Epithelial Ovarian Cancer and Is Associated with Immune-Infiltrating Cells
por: You, Shijing, et al.
Publicado: (2022) -
Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours
por: Wang, Fujun, et al.
Publicado: (2023) -
Loss of the Volume-regulated Anion Channel Components LRRC8A and LRRC8D Limits Platinum Drug Efficacy
por: Widmer, Carmen A., et al.
Publicado: (2022) -
Emodin inhibits TGF-β2 by activating the FOXD3/miR-199a axis in ovarian cancer cells in vitro
por: Song, Kejuan, et al.
Publicado: (2018) -
LRRC15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity
por: Krishnamurty, Akshay T., et al.
Publicado: (2022)